Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Maastricht University Medical Centre](/img/noimage_org.png)
Maastricht University Medical Centre
Maastricht, HolandaPublikationen in Zusammenarbeit mit Forschern von Maastricht University Medical Centre (5)
2024
-
Additional Guidance on the Use of the PRESERFLO™ MicroShunt in the Treatment of Glaucoma: Insights from a Second Delphi Consensus Panel
Ophthalmology and Therapy, Vol. 13, Núm. 6, pp. 1569-1588
2022
-
Correction to: Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel (Ophthalmology and Therapy, (2022), 11, 5, (1743-1766), 10.1007/s40123-022-00529-4)
Ophthalmology and Therapy
-
Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel
Ophthalmology and Therapy, Vol. 11, Núm. 5, pp. 1743-1766
-
Reply
Ophthalmology Glaucoma
-
Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study
Ophthalmology Glaucoma, Vol. 5, Núm. 2, pp. 195-209